Warning: The story you're about to read tells of the very disturbing scenes from...

The Most Drug-Addicted City in the World

double-down-arrow-white

Dear friend,

What you're about to read is 100% true...

It began around 6:30 p.m. on Thursday, August 3, 2017, when President Donald Trump landed at an obscure airport in the far-west part of West Virginia.

The airport, named Milton J. Ferguson Field, sits right where Appalachia ends and the Rust Belt begins. It serves as the main air hub for a small city called Huntington.

Trump was in Huntington for only two hours. But what the White House saw and heard within that short period of time was so distressing...

That just two months later, on October 10th, Air Force One landed there again.

But this time, First Lady Melania Trump was onboard for her first official state visit. That little tidbit didn't make many headlines with the mainstream media. Barely anybody covered it aside from local news stations.

But it would later turn out to be very important, as you're about to find out...

Why?

Well, Huntington is anything but a political powerhouse or an economic force.

In fact, it's considered one of the worst cities in America.

It's always on the "Top 10 Worst Places to Live in West Virginia" lists. And it regularly makes the "10 Most Miserable Cities in America," taking top honors as recently as 2015.

Having suffered through six-straight decades of economic decline, it's one of America's poorest cities. It has an extremely low median household income that's only 66% of the national average.

To make matters worse, it has the nation's highest obesity rate. And it's in the top 10 for heart disease, diabetes, cancer, and other chronic diseases.

With one of the lowest life expectancies in the entire nation, the city has basically been forgotten and left for dead.

Now, I should tell you that I've been to Huntington at least a few dozen times throughout the years. And it's even worse than how I described. I've seen with my own eyes how depressed and dilapidated the city is.

So, when a sitting American president and his wife visited it not once but twice within two months, it caught my attention. I knew that there had to be a reason. And I knew that the reason had to be something serious.

It didn't take me long to find out why...

Despite all the problems I just laid out, Huntington has an even bigger problem — one that's gained worldwide attention...

It's the capital, ground zero, of the deadliest drug crisis in American history: the opioid epidemic.

Opioids, or painkillers as they're commonly known, are the second-most prescribed class of pharmaceutical drugs in the U.S. — right behind cancer medicine.

They get their name because they're derived from opium poppies.

I'm sure you're familiar with opium poppies because the deadly drug heroin is also made from the opium produced by the plant.

But heroin aside, there's a whole host of legal pharmaceutical painkillers that are produced from opium and synthetic opium. You know these drugs by their modern, medical-given names: OxyContin, oxycodone, morphine, Percodan, Percocet, and the latest deadly drug to hit America, fentanyl.

They're commonly given to patients as pain relievers after surgeries and to people suffering from chronic diseases or physical ailments.

But because these drugs can give patients intensely pleasurable feelings of euphoria, they're also being prescribed to ease stress, anxiety, and depression.

And they're wildly effective in that regard.

As a result, billions of prescriptions for opioids have been flooding America since the 1990s.

But here's the dark side...

These drugs are so addictive that many people get hooked the very first time they try one.

And this is why it's brought the entire city of Huntington to its knees...

An American City Under Siege

Now, the numbers that I'm about to show you are downright shocking...

  • 20% of Huntington's population is addicted to drugs — 20%!
  • 1,831 overdoses were reported in 2017, up by more than 600 from 2016.
  • And last year, one resident died every 10 hours of an overdose.

Huntington Fire Chief Jan Rader told NBC's Meet the Press: "It's been years since we had a day without an overdose."

It's so bad that one late afternoon in August, paramedics responded to 25 overdose calls within a three-hour period.

This is unprecedented.

And it's why the Trump administration went there twice last year.

You see, the crisis playing out in that remote Appalachian city isn't unique. It's spreading like wildfire all across the U.S.:

In fact, opioids now kill more Americans than guns and automobile accidents combined:

It even kills more people than many types of cancer.

Think about that...

So, when Trump returned from Huntington, he knew that something had to be done right away to fight the deadliest drug epidemic in American history.

He immediately declared the opioid crisis a national emergency and allocated $17 billion to the fight.

And it's already producing positive, lifesaving results.

So, let me tell you about...

Huntington's Cure

double-down-arrow-white

As you read this presentation that I've prepared for you, Huntington is throwing everything it has at the drug epidemic. And I mean everything...

  • Lifesaving drugs.
  • Medical and law enforcement resources, such as more police, EMTs, and schools carrying anti-overdose drugs.
  • And maybe most important of all, more treatment facilities.

Even the West Virginia National Guard was sent into the city to help!

It's an all-hands-on-deck effort to fight this crisis.

Now, here's some good news...

Overdose deaths in Huntington have dropped in half in 2018!

That's right: in half.

The media has called Huntington's approach "pioneering."

It's been so successful that "Huntington's cure" is going nationwide.

States, cities, and towns are now looking at Huntington as a template to use to fight their own drug problem.

And as a result, these states, cities, and towns are looking at three small, yet innovative and visionary, companies that have been working for years on a cure for opioid addiction.

All three companies address the three most important and difficult challenges of this drug epidemic:

  1. Prevention.
  2. An overdose antidote.
  3. A safe, nonaddictive pain reliever to replace opioids altogether.

Here's what I'm talking about, and here's how we'll solve this deadly problem.

First, one of the three companies has a recently U.S. Food and Drug Administration (FDA)-approved, anti-addiction drug so good that doctors are calling it "a game-changer." And it's because a single dose of it can stop the most severe drug cravings for up to six months at a time!

So, imagine a person who's currently addicted to an opioid. If they were to use this new drug, it would stop all their opioid cravings for up to six months at a time.

This really is a game changer. This drug could be prescribed to the more than 20 million Americans who are currently using or addicted to opioid painkillers.

I'll tell you more about this drug's promise to end the crisis in a minute. The company that makes this drug trades on the Nasdaq for only $1 a share.

But it's only one of three that have blockbuster potential. I'm just as excited about the other two companies.

For instance, one of the three — which trades on the Nasdaq for less than $25 a share — has already saved tens of thousands of lives with its anti-overdose drug. This drug reverses the effects of an opioid overdose within seconds. It literally brings people back from the dead.

The company's flagship anti-overdose drug is being used by nearly every single hospital, paramedic, and police officer in America. Schools are starting to use it, too, and so are regular everyday citizens.

In fact, the U.S. Surgeon General Dr. Jerome Adams, the top medical doctor in America, issued a rare national advisory last April. He urged more Americans to carry the drug with them at all times — the same way that parents and people with severe life-threatening allergies carry an EpiPen everywhere they go.

Surgeon General Jerome Adams said:

I, Surgeon General of the United States Public Health Service, VADM Jerome Adams, am emphasizing the importance of the overdose-reversing drug... For patients currently taking high doses of opioids as prescribed for pain, individuals misusing prescription opioids, individuals using illicit opioids such as heroin or fentanyl, health care practitioners, family and friends of people who have an opioid use disorder, and community members who come into contact with people at risk for opioid overdose, knowing how to use [it] and keeping it within reach can save a life.

Most states and many cities have already issued standing orders that allow anyone to get the lifesaving drug at a pharmacy without a prescription. Most insurance plans cover it. And people can sometimes get it for free or at a low cost through public health programs or manufacturer discounts.

But this is the first time that a U.S. surgeon general has issued such a statement.

That's how effective the overdose-reversal drug is at saving lives.

And it's so easy to administer that young children have used it to save their parents from overdosing on opioids.

The company that makes it is working overtime, around the clock, to produce as much of this lifesaving drug as it can.

Oh, by the way, the company's stock has already tripled in price within only a year's time. From here, it could go to $52 a share within the next 12 months — easily.

This company is so undervalued and so under the radar that it could go up 10 times its current price and still be considered dirt cheap.

The third company might be the most promising of them all. It's developing a painkiller to replace opioids altogether. The drug it's developing is from a formerly forgotten compound that's been proven safe, nonaddictive, and has no known negative side effects.

It was first used as a pain reliever in the 19th century. But it was dropped from any further research once opium and morphine were discovered as effective painkillers.

In a few minutes, I'll give you all the details on how to invest in these companies and why that's vitally important to the success of this fight.

But first, I need to explain why it's urgent that we fight this deadly epidemic with everything we've got — right now...

Why a Cure Couldn't Come Sooner

Opioids now kill over 72,000 Americans per year. That's more than AIDS killed at its height in 1995.

In 2016 alone, opioids killed more Americans than those who'd died in the Vietnam War!

And with 110 people overdosing every single hour, it's getting worse by the day.

So far, 12 governors and countless counties have declared states of emergency over the epidemic. And it's destroyed entire generations across small towns and cities from Portland, Maine, to Columbus, Ohio; Shasta, California; the tri-cities in Washington, and everywhere in the between.

FDA Chief Scott Gottlieb pleaded for help in a recent interview with CNN...

"[The opioid epidemic] is the biggest crisis facing the FDA."

But it's gotten even worse...

Warning: Viewer discretion is advised.

Okay, so this is the part of the presentation that is, quite frankly, heartbreaking and emotionally shocking. So, I have to warn you that what you're about to see is disturbing and may bring you to tears. But it's important that you see it. It could not only change your life but also the lives of all the people suffering from this terrible addiction.

And that's because the opioid epidemic took a downright horrifying turn. It's the reason that the first lady went to Huntington last October in the first place.

She went there to visit a drug rehabilitation facility that's the first of its kind in the nation. It's a rehabilitation center that caters to a unique group of patients...

It's a rehab center that solely treats newborn babies going through opioid withdrawal.

That's right: Babies born into rehab.

You see, of the 2,900 babies born last year in Cabell County, which is where the city of Huntington is, 500 were born to mothers addicted to painkillers. These 500 babies had to be weaned off drug dependence.

And that's just one county out of over 3,000 counties in the U.S.!

In the neighboring states of Kentucky and Ohio, two more rehab facilities for newborn babies have opened.

Kentucky has been hit particularly hard by the epidemic. It has twice the U.S. rate of drug-dependent newborn babies.

Ohio is no better. It's seen an 800% increase in the number of babies born dependent on opioids.

Many more rehab centers like these are set to open nationwide within the coming months.

In Pennsylvania, for example, some counties are seeing 45 drug-dependent newborn births out of every 1,000.

And across the U.S., a baby is born every 25 minutes suffering from opiate withdrawal.

Sadly, that's over 21,000 opioid-dependent babies born every year. And that number is increasing as the crisis spreads.

Let that sink in while I explain how this happens.

According to recent medical literature...

Opioids pass readily from a pregnant woman's bloodstream through the placenta and across the fetal blood-brain barrier. When birth abruptly shuts down the flow of the drug, the baby's nervous system can trigger the agitating symptoms of withdrawal. Studies show than 55 percent to 94 percent of newborns exposed to opioids develop symptoms.

So, it's almost certain that most newborn babies exposed to these drugs will go through some kind of withdrawal.

And what these poor babies go through is heartbreaking.

According to a nurse who's been treating newborns going through drug withdrawal...

The babies shake uncontrollably, sweat, vomit, and their bodies cramp and go as stiff as planks. They eat and sleep fitfully. They are hypersensitive to bright light. Other times, they're fidgety. And the thumb sucking... it's never ending — unusual, even for newborns.

 

It's a real-life nightmare.

Quite frankly, as a father of three, it angers me beyond belief to see the torture that these innocent babies go through.

I'm furious, in fact.

But it's also motivated me to not just sit back and watch this disaster unfold. Because of my position as a professional investor, I'll instead be a part of the solution.

And that's why I'm recommending for immediate purchase the small stocks that I mentioned earlier. I call them "3 Stocks to Cure America's Drug Crisis."

They trade for $25 a share, $1 a share, and $4.60 a share.

They all trade on the Nasdaq and are all very liquid. Plus, they're super easy to buy.

Like I said, these stocks are small. But once the fight against opioids goes nationwide, these stocks will skyrocket in price.

The $25 company, for instance, is a small firm out of California. I say small because its market cap is only about $70 million.

But check this out...

Ever since the company launched its lifesaving overdose-reversal drug, the stock has tripled in value.

And it gets better...

Sales for its lifesaving drug have skyrocketed. It's gone from $5 million only a few years ago to $29 million today.

And remember the small California firm with the FDA-approved drug that stops even the most severe opioid cravings in its tracks? The one that trades for $1 a share?

Its revenue went from $1.6 million in 2015, a year before its drug received FDA approval, to over $15 million after its approval.

In a minute, I'll tell you the name of the firm and the drug and also how you can get a piece of both for only $1.

I plan to snatch up as much as I can at these discounted prices.

And with Trump promising at least $17 billion to throw at this problem, this drug and the firm that owns it are guaranteed to be involved in a major way.

I'll lay it all out for you...

But first, I want to introduce myself.

My name is Jeff Siegel. I've been a professional investor for three decades.

But I'm also a best-selling author, television and radio commentator, libertarian activist, farmer, and editor of the highly successful investment publication Green Chip Stocks.

I'm also what you might call a "compassionate capitalist." I go out looking for problems to fix through the power of the free market...

Find a Crisis; Profit From the Solution

double-down-arrow-white

Well, as the old Chinese proverb says, "Crisis is opportunity." Some of the world's most pressing and deadliest problems have also been some of the most profitable.

I don't say that as a heartless profiteer — quite the contrary. I say it because the free market is the greatest tool ever invented by man for positive life-changing progress.

The startling truth is that almost all of human progress has taken place within the last 300 years following the creation of capitalism and during the industrial revolution mainly in Europe and North America.

When Asia, South America, and Africa embraced free markets, something that occurred only within the last 40 years, it lifted billions of people out of crushing poverty.

In fact, it's been the fastest wealth-creation and poverty-reduction period in the history of mankind.

That's why I look to the free markets to eradicate some of the world's most difficult and deadliest problems.

And for years, I've been helping investors like you invest in solutions to many of those problems.

In fact, that's the entire premise of my investment publication Green Chip Stocks: Identify a problem, crisis, or need, and then find a solution — a profitable solution.

And it's worked like magic.

For example, when I started Green Chip Stocks almost 14 years ago, I focused most of my attention on renewable energy.

Why?

Because in 2004, the world was facing a problem of historical proportions...

It was one that could've collapsed countless companies, pushed a billion or more people out of work, and brought the global economy to its knees. Another world war wasn't out of the question:

Even the Pentagon was preparing for the worse. It was a dangerous time.

I'm talking about the spike in oil prices that started in 2004.

You see, the world was facing a sudden and catastrophic shortage of oil at the same time that the emerging Chinese and Indian economies were demanding more and more of the precious liquid.

New oil discoveries around the globe had dropped dramatically while existing giant oil fields that had supplied us with plentiful oil for decades were experiencing devastating declines in production.

It was a perfect storm for astronomical, higher energy prices. And it happened as I predicted:

To avert a global economic collapse, I knew that rising oil prices would spur huge investments in not only fracking but also in solar, wind, geothermal, natural gas, and the electrification of the transportation industry.

And it did...

Billions of dollars poured into startup renewable energy companies as gasoline, natural gas, and oil prices rose to unimaginable levels. And I had my readers positioned to take advantage of it.

My readers made a fortune.

I was the first newsletter editor to recommend the solar panel manufacturer SunPower Corporation (NASDAQ: SPWR), which rose from $25 to $124 within only a few short years:

We also made 850% on First Solar (NASDAQ: FSLR) within only two years:

But we weren't done...

We took a position in geothermal energy supplier Ormat Technologies (NYSE: ORA) when nobody even knew that geothermal was a viable source of energy. Ormat's shares went from $17 a share to $70. We made a killing:

And then there was Vestas Wind Systems (OTC: VWDRY), a European wind turbine behemoth. It went from $75 a share to over $660. And it's now an $84 billion company:

gcs-opioid-vestas

Renewable energy is now the fastest-growing industry in the energy sector. And Green Chip Stocks was there from the beginning:

gcs-opioid-global

And that led to another big investment opportunity...

Electric Vehicles

double-down-arrow-white

As gasoline prices at the pump steadily rose to over $4 and $5 a gallon, investment capital started to pour into companies developing electric vehicles (EVs).

There were a lot of naysayers. But I knew it was only a matter of time before the EV market took off. And it did.

I'd been following Elon Musk and his Tesla Roadster from the beginning. The company was blazing a trail in the EV market that few could duplicate.

Tesla had everything: a sporty, futuristic design; the technology to the make it all happen; and the best engineers to pull it off.

But more importantly, Musk had the battery!

Owning and manufacturing the battery was the key to Telsa's success.

And even though almost every Wall Street analyst said it couldn't be done, I knew it could. And I had my readers positioned for Tesla's initial public offering (IPO).

Tesla's stock is up by over 1,700%!

It's now worth more than Ford, Fiat Chrysler, BMW, Honda, and Nissan.

In fact, it's only $1 billion away from overtaking American automobile giant General Motors.

And it's all because Tesla's revolutionary EV solves a major problem. And that's how I help my readers make money:

But I have to tell you, nothing compares to what we've done, and continue to do, in the medical marijuana space...

Cannabis: The New Big Pharma

I won't lie...

Investing in cannabis has made members of my Green Chip Stocks community and me mountains of cash.

We got in early on some of the biggest cannabis players in the world before they became "the biggest cannabis players in the world."

I'm talking about companies like...

  • Canopy Growth Corporation (TSX: WEED), currently up by 4,255%!
  • OrganiGram Holdings (TSX: OGI), currently up by 1,502%!
  • Aurora Cannabis (TSX: ACB), a gain of 190%!
  • The Green Organic Dutchman (TSX: TGOD), which is up by a stunning 1,276% after only six months!
  • Aphria (TSX: APH), currently up by 1,563%!
  • And that's only a small sampling...

The truth is, I've made more money from the cannabis space within the past three years than I've made from anything else since I first got into the investment game back in 1994.

And it's easy to see why...

Marijuana is quickly becoming the largest cash crop in the world. And the wealth is growing like, well, a weed.

According to data from the United Nations, the global market for illegal drugs is worth more than $300 billion per year. And marijuana monopolizes almost half of that to the tune of $142 billion. To put that into perspective, the global coffee market — one of the most valuable commodities on the planet — is valued at about $80 billion per year.

Its market value exceeds that of corn and wheat, too. It's actually considered to be the largest cash crop in the U.S. It enjoyed a growth rate of 77% from 2013 to 2014 and an estimated 700% growth rate by 2019.

But here's the best part...

Not only has cannabis helped me in creating enormous wealth, but it's also helped me in supporting companies that produce cannabis to treat the sick.

That's right, cannabis isn't just for stoners and hippies. For centuries and across many cultures, cannabis has been widely used for medical purposes.

Truth be told, cannabis is a wonder plant with almost unlimited medical applications.

And that's why I've been heavily investing in the marijuana space way before the mainstream public did — and way before Wall Street. Quite frankly, it's why the Green Chip Stocks service exists in the first place.

The next big investment in cannabis will be its promise to cure the opioid crisis that's currently gripping America.

It'll be a huge winner for investors who have the foresight to get in on this space before everybody else does.

I know you'll be one of them...

But before I go any further, let me begin with a true story of a little girl named Harper Howard. She's one of the main reasons that I went all in on medical marijuana.

Harper was born on April 12, 2010, with a rare genetic disorder called CDKL5 epilepsy.

At two weeks old, Harper began having severe seizures. At her worst, she was having 40 seizures a day and none of the conventional therapies were working.

Now, this little girl was born with a disorder that would undoubtedly take her life. And although her life was certain to be short, her mother, Penny Howard, didn't want those short years to be "unlivable."

So, as any good parents would, Penny and her husband searched frantically for something that would ease their daughter's seizures. And they found it in cannabidiol (CBD) oil.

CBD is a chemical compound found in cannabis. And when the oil is extracted from the stalk of a hemp plant, it has a wide range of medical benefits, as the parents of Harper soon discovered.

Within two weeks of starting to use the oil, Harper's seizures were cut in half. And after honing in on the right dose, the seizures eventually ended completely.

Let me say that again: Her seizures ended completely!

What followed was exciting...

Here's an excerpt from a piece that Harper's mother wrote:

I'll never forget giving the CBD oil to Harper and seeing the immediate impact it had on her quality of life. Within the first three days we had eye contact and verbalization sounds from her, an attempt to interact with us physically and she was now able to show us that she was with us mentally. It wasn't long before she went a day without a seizure! And then another day without a seizure!

Before we knew it she was at 45, 50 then 60 days without a seizure. Harper even came out of her stupor, her shell, and interacted with the family, we got her little personality back. She got to meet her baby brother Seth after he was born late in 2014.

How was this even possible? After three years of living in hell there was finally light! Harper does not simply exist here on Earth but rather she lives!

The big discussions around cannabis these days tend to center on the legalization of cannabis for recreational purposes. But as investors, and just as decent human beings, the reality of cannabis being used as an effective treatment for hundreds of diseases and ailments is one that shouldn't be trivialized.

There's loads of evidence showing that cannabis can serve as an effective treatment for epilepsy. But that's just the tip of the iceberg.

I'll show you why this is important and why cannabis is being developed in the fight against the current opioid epidemic in a minute...

Even though studies on medical cannabis have been limited because of the prohibition of cannabis in the U.S., more and more research is now being carried out as legalization starts to take hold around the world.

The result...

We're now finding that cannabis can serve as an effective treatment for a lot of major illnesses. This includes but isn't limited to...

  • Alzheimer's.
  • Tourette's syndrome.
  • Traumatic brain injury.
  • Migraines.
  • HIV.
  • Depression.
  • Crohn's disease.
  • Autism.
  • Arthritis.
  • Multiple sclerosis (MS).
  • Post-traumatic stress disorder (PTSD).

The list goes on and on...

And this means two things:

  1. A lot of people who suffer from incurable diseases are now finding effective treatments and therapies from cannabis.
  2. Investors have the opportunity to invest in the companies that are providing these new cannabis-based therapies. And these therapies, in some cases, are now being chosen over conventional therapies and drugs.

It's almost as if there's a new Big Pharma being incubated in the world of cannabis.

And make no mistake, there's a boatload to be made by getting an early piece of this new Big Pharma...

This Is a Revolution

double-down-arrow-white

For the record: I'm not anti-conventional medicine.

Let me make that perfectly clear.

But conventional medicine doesn't always work. And if there's a viable alternative, rest assured, it will be used and, of course, prove profitable.

According to Grand View Research, the complementary and alternative medicine market is expected to generate up to $200 billion by 2025. And this market doesn't really address some of the bigger diseases, such as Alzheimer's, HIV, and MS.

But cannabis does. And that makes the industry incredibly powerful and lucrative.

And that, dear reader, is why we're taking early positions in the cannabis companies that have first-mover advantages and are leading the way in mainstreaming medical cannabis.

As I showed you earlier, we've already landed some pretty big winners in the cannabis space.

And honestly, we're still in the earliest stages of growth.

Although, this year is looking to be the biggest yet...

With California having recently fully legalized last January, and the entire country of Canada set to legalize this summer, the market is ready to explode.

Heck, even Mexico is legalizing cannabis now.

And outside of North America, cannabis is now legal in some form in Australia, Colombia, Denmark, Spain, Uruguay, Israel, Italy, Germany, Finland, and Argentina.

My prediction is that within the next 10 years, cannabis will be fully legalized or legalized with some minor restrictions in all 50 states.

This will be a boon for investors who get in right now while companies are continuing to develop cannabis-based drugs to cure many of the world's deadliest diseases.

Make no mistake: A real revolution is taking place. And it'll help a lot of sick people find the medicine they need. And that, of course, offers a huge opportunity to investors who get in while it's still early.

That's why the third company included in my "3 Stocks to Cure America's Drug Crisis" is a small biotech company headquartered in Israel. And it's developing a cannabis-based drug to completely replace opioids.

gcs-drug-crisis_report-v2

It's taking the CBD oil found in marijuana plants, the same CBD oil that's currently eliminating epileptic seizures, to produce pain relievers that are just as good as opioids but without the addictive side effects.

Think about that for a second...

Opioids are the second-most prescribed pharmaceuticals in America. If this biotech company can produce a painkiller that can completely replace all opioids, imagine the hyperbolic growth that the company's stock will have.

It would be a blockbuster.

In fact, it could easily be a more than 10,000% winner, generating tens of billions of dollars in profit.

And I want you to invest in this $4.60 company, plus the other two stocks that I talked about earlier, starting today!

The Only Investment Service of Its Kind

In 2004, I started Green Chip Stocks to show investors how to "do well by doing good."

We focus exclusively on socially responsible investing with companies in sectors like renewable energy, organic agriculture, life science, and legal cannabis.

But don't let the fact that I'm known as the "libertarian tree hugger" fool you...

Many of my recommendations have made serious money for our subscribers!

You could have earned 201.2% on Ormat Technologies, which would have been enough to triple every dollar you'd invested.

We did 328.11% on Mettrum Health Corporation (TSX: MT), a $3,281 payday on every $1,000.

Shake Shack (NYSE: SHAK) gave us a 72.62% return, a $7,262 windfall on only $10,000 of capital.

Tesla (NASDAQ: TSLA) was a 552.5% rocket that turned every $5,000 on this recommendation into $27,625.

And those weren't even our biggest winners. Some of those include...

  • 1,563% with Aphria.
  • 1,502% with OrganiGram Holdings.
  • 4,255% with Canopy Growth Corporation.

On Canopy Growth alone, a piddling $500 investment would have soared to more than $20,000 in profits!

With a $25,000 stake, you'd be looking at a cool $1 million!

That's a million bucks from just one stock!

For most investors, that would be a once-in-a-lifetime win...

The kind they could brag to their golf buddies about for years and years.

For Green Chip Stocks subscribers, that's just another day and another massive gain.

See what Kirk M. writes:

"I was reading my e-mail and got the sell alert a few minutes after your issuance and sold all 40,000 shares of [censored]. I made a nice 32k profit."

Mary T. says:

"I recently took your recommendation to buy [censored], and it is doing great! Thank you, I only wish I had more money to invest in it!"

Peter H. shares:

"Jeff, yes, thanks! Loaded up my boat, well at least for my size portfolio, 5000@ avg of $1. So $5K is now $20K."

Al C. writes in to say:

"Jeff: Thank you so much for your publication. Over the last year I have bought [censored] on four different occasions parlaying my gains into where we are today. My gain thus far is almost 300% on my total investment. Keep up the great work and thank you so much!"

Rene L. shares:

"Hi Jeff, my entry point was $0.99, so my score is 332%. Very good! And thanks."

Steven S. writes:

"I put 30% of my IRA portfolio in [censored] when I first purchased your newsletter. When I saw the first big dip I put another 20% of my portfolio (from selling SLV - Silver iShares) into it. Today I ended the day with a 64% gain. That's $25,000 in the green on my investment! Thank you for the hot tip."

And as extraordinarily excited as my subscribers are now...

They're even more excited to be a part of the solution to the deadliest drug crisis in American history: the opioid epidemic.

By now, you know the huge challenges that the opioid problem poses:

  • Over 20 million American use opioids.
  • Over 2 million are chronically addicted to the drugs.
  • And over 72,000 Americans are dying from overdoses each year. That's more than from automobile and gun deaths combined.
gcs-drug-crisis_report-v2

But a solution is on the horizon with the three small but visionary companies I've been talking about. And you can get the names and all the details about their lifesaving drugs in my exclusive report: "3 Stocks to Cure America's Drug Crisis."

Each company's lifesaving drug addresses a specific need in this battle against opioids:

  • Drug No. 1 suppresses the deadly drug cravings that opioids create.
  • Drug No. 2 saves lives by quickly reversing the effects of opioid overdoses.
  • And drug No. 3 replaces opioids altogether with a new, safe, and nonaddictive painkiller.

Fix those three problems, and the opioid epidemic would go away. It's that simple.

And now, you have a way to be invested in the cure...

Buy These 3 Companies Now

double-down-arrow-white

All three companies are still small and are still flying under the radar of Wall Street.

Why?

Well, it wasn't until recently that the U.S. finally recognized that it had an opioid problem. And it wasn't until the election of Trump that a sitting American president was willing to tackle the problem with the resources of the federal government.

So, in other words, this battle is only in the beginning stages.

The first company featured in "3 Stocks to Cure America's Drug Crisis" is a $1 drug developer out of San Francisco.

Its drug is being hailed as a "game-changer" for one big reason...

You see, unlike the majority of anti-addiction drugs that have to be administered on a daily basis, this company's drug lasts for six months at a time.

The patient takes it once, just once, and comes back for another dose in six months.

And this drug treats both pains while weaning users off more powerful addictive opioids. So, it's a win-win.

The drug delivery method is what makes this company a game changer and a vital player in the war against opioids.

The company has a minuscule market valuation of only $20 million. A stock that small with this much potential at saving lives? We're talking about a moonshot!

The second company in my report is also out of California. It makes the drug that reverses the effects of opioid overdoses. It literally brings overdose victims back from the dead.

 

If it weren't for this drug, thousands more Americans would be dying from overdoses every year.

This overdose-reversal drug is so vital in the fight against opioids that the company's top brass has had several meetings at the White House to work on a strategy to go nationwide.

All medical emergency personnel — EMTs, firefighters, police officers, emergency room doctors and nurses, and even schoolteachers — have access to this lifesaving drug.

Heck, even middle school students in hard-hit states like Kentucky and New Hampshire are being trained to administer the drug.

And like the first company I talked about, this one is also very small. It trades at a market valuation of only $70 million.

But it's growing fast. Its revenue went from $5 million to $18 million to $28 million within three years!

The company's stock recently went public. And it quickly tripled in value over the past 12 months.

And it could easily go up another 10 times, and it'd still be undervalued.

Finally, the third company featured in "3 Stocks to Cure America's Drug Crisis" is the drug firm in Israel that's developing a completely safe, effective, and more importantly, nonaddictive cannabis-based painkiller set to replace the opioid market altogether.

Israel is a hotbed for revolutionary technology and medicine.

With a population of only 9 million people, Israel has the third-most companies listed on the Nasdaq!

And it's easy to see why. Israel has more Ph.D.s, M.D.s, and other advanced degrees than any other nation. And it's among the top five of nations for per capita scientific publication output. It has more doctors, lawyers, engineers, and entrepreneurs per capita than any other nation. The number of high-tech firms located in Israel is exceeded only by the U.S.' Silicon Valley region.

The tiny nation regularly makes Bloomberg's list of top most innovative nations year after year. And it's always in the top 10 for patents filed and granted.

In fact, this past July, the FDA asked Israel to fast-track its non-opiate painkiller program.

That's all I needed to hear to invest in this company's stock.

And like the other two companies in the report, it's a small firm with an undervalued market valuation of only $150 million.

I'll give you all the details on this company, its name, and its stock symbol. And I'll explain why it's headed for over $50 a share from its current per-share price of only $4.60 when you take a test drive of Green Chip Stocks...

Be a Part of the Solution:
Give My Advisory Research Service a Test Drive

When you sign up for a membership to Green Chip Stocks, I'll rush you your copy of "3 Stocks to Cure America's Drug Crisis."

And then, we'll continue providing you with ongoing, up-to-the-minute real-world advice, strategies, and tips on how to create the life of your dreams.

As a member of the Green Chip Stocks community, you'll get...

  • Green Chip Stocks. This is my personal website where I post every urgent update that you'll need to profit from the opioid epidemic and the green tech industry.
  • Three full-length reports. You'll get immediate access to three of my latest investment reports, in addition to my newest report: "3 Stocks to Cure America's Drug Crisis."
  • Weekly updates. Once a week, I'll update you on the investment opportunities that I've shown you. This includes any hot details on the opioid cure trade that I've already told you about.
  • Private research trips. As an active member of Green Chip Stocks, you'll be able to join me on private research trips that are only available to this private investment group. You'll also be able to attend private investor dinners that I hold exclusively for my inner circle of like-minded investors.
  • Direct support. As long as you're a member of our community, you'll be able to contact me with any questions you may have. My staff and I will be happy to work with you.

I'm committed to making sure that you get the full value of your membership.

So, at this point, you're likely wondering...

How Much Will It Cost for Access?

And I have to admit, for a long time, I was stumped on that, too. How do you set a price on information that could pave the way for a very comfortable early retirement?

And not just for you but also for the next four generations of your family...

Because that's the scenario we're looking at here.

When the real possibility exists of 100 times returns, even a microscopic investment of a few thousand dollars could pay you a fortune. And with $10,000, $20,000, or more...

You might never need to buy another stock again.

And my special report is only one piece of what you'll be getting today.

As a member of Green Chip Stocks, you'll have a full year of trades, like...

  • 417.39% from True Leaf Medicine International Ltd. (CSE: MJ).
  • 70.82% from Vivint Solar (NYSE: VSLR).
  • 102.75% from Carmanah Technologies Corporation (TSX: CMH).
  • 275.56% from Emerald Health Therapeutics (TSXV: EMH).
  • 503.3% from First Solar.
  • 675% in THC Biomed International Ltd. (CSE: THC).

A mere $10,000 invested in each of those stocks would have paid more than $260,000.

With $260,000, you could buy a brand-new Ferrari, take a high-end cruise around the world, or even get an oceanfront condo on the beaches of Mexico.

Now, normally, a service like this would cost $5,000 to $15,000 or even more...

And it would only be available to hedge funds and investment banks.

Ordinary investors simply wouldn't be allowed in.

But I've devoted my career to socially responsible investing. And a big part of that means giving back to regular folks like you — investors who've never had a shot.

So, even though Green Chip Stocks is a platinum service...

You won't have to pay platinum prices to get in.

In fact, you won't even have to pay the regular full price of $199.

Today, you can get full access for the next 12 months for only $99.

So, when you're ready to get started...

Simply click the Join Now button below.

When you do, you'll get all the details on the three stocks that are poised to go on a once-in-a-lifetime rally to over 1,000% starting this year. You'll also get all the exclusive information on the members-only Green Chip Stocks website where I have all my reports and investment guides...

Not to mention, all my double- and triple-digit recommendations.

But I'm not stopping there. If you join me today...

I'll give you access to three bonus reports, ABSOLUTELY FREE:

  • BONUS No. 1 — "How to Become a Legal Drug Dealer: A Beginner's Guide to Getting Rich in the Legal Cannabis Market."
  • BONUS No. 2 — "How to Get Rich by Saving the Planet: An Investor's Guide to Socially Responsible Investing."
  • BONUS No. 3 — "The Rise of Wind: The One Wind Stock to Own Now."

All three bonus reports will be yours for FREE when you agree to give Green Chip Stocks a try.

The intel available in just one of these special briefings could pay for your membership many times over.

If that sounds like a great deal...

Simply click the Join Now button right away!

Each of the three stocks that we've picked to lead the opioid cure has the potential to change the world and line our pockets in the process.

All you'll have to do is take a small leap of faith. So, when you're ready...

Simply click the Join Now button to get started.

Please, don't wait too long to make your decision.

If you want in on the cure for the deadliest drug epidemic in American history, you must act fast...

The train is leaving the station!

Fortunately, the massive gains are still ahead of us.

Every single one of these stocks is still considered a micro cap.

This means that there's still time for you to get in on the ground floor.

But you'll need to take action immediately.

Simply click the Join Now button right now!

I'll see you in the Green Chip Stocks member's area.

Thanks and have a great day!

Sincerely,

Jeff Siegel Signature

Jeff Siegel
Investment Director, Green Chip Stocks

join-now-blue